“COST-EFFECTIVENESS ANALYSIS OF AUGMENTIN 625 MG AND AUCLANITYL 500 MG/125 MG IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA”, YHCĐ, vol. 67, no. CD15, Sept. 2026, doi: 10.52163/yhc.v67iCD15.6792.